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Abstract
Purpose This study evaluated the effectiveness and coaching
labor requirements of a web-based automated telehealth (TH)
messaging program compared with standard of care (SOC) in
newly diagnosed patients with obstructive sleep apnea (OSA).
Methods In this non-blinded, multicenter, prospective study,
all patients were started on continuous positive airway pres-
sure (CPAP) with heated humidification and a wireless mo-
dem. They all received standardized CPAP education and set-
up. Patients in the TH group (n = 58) received an automated
series of text messages and/or e-mails that were triggered by
preset conditions. Patients in the SOC group (n = 64) received
scheduled calls on days 1, 7, 14, and 30. Additional contacts
were allowed for patients in both groups as deemed clinically
necessary. Coaching labor was calculated by totaling the num-
ber and type of patient contacts and assigning historical time
values.
Results One hundred twenty-two patients were included in
the final analysis. There were no statistically significant dif-
ferences between the TH and SOC groups for Medicare ad-
herence (83 vs. 73 %), daily CPAP usage (5.1 ± 1.9 h vs.
4.7 ± 2.1 h), CPAP efficacy (mean residual apnea-hypopnea
index (3.0 ± 4.1/h vs. 2.8 ± 3.8/h), or change in Epworth
Sleepiness Scale score (−5.8 ± 5.5 vs. –5.1 ± 5.9), although
all trends favored the TH group. There was, however, a sig-
nificant reduction in the number of minutes coaching required
per patient in the TH vs. SOC group (23.9 ± 26 vs. 58.3 ± 25,
59 % reduction; p < 0.0001).
Conclusions Use of a web-based telehealth program for
CPAP adherence coaching significantly reduced the coaching
labor requirement compared with SOC, while maintaining
similar adherence and effectiveness.
Keywords Obstructive sleep apnea . Telehealth . Continuous
positive airway pressure . Adherence . Compliance coaching .
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Introduction
Obstructive sleep apnea (OSA) is the most common form of
sleep-disordered breathing (SDB) and is typified by repetitive
complete or partial collapse of the upper airway during sleep.
The prevalence of OSA has been increasing steadily, in part
due to the rise in obesity, with recent estimates suggesting that
it affects ≥13 % of men and 6 % of women [1, 2]. This repre-
sents a considerable growth rate of 14–55 % over the past two
decades [2]. OSA has been associated with numerous co-
morbidities including hypertension, congestive heart failure,
stroke, diabetes mellitus, and an increased risk of motor vehi-
cle accidents [3–10]. OSA places a substantial financial bur-
den on the healthcare system, with the cost of untreated OSA
estimated to be US$67–165 billion [11].
First-line therapy for OSA is continuous positive airway
pressure (CPAP), which improves symptoms including exces-
sive daytime sleepiness, fatigue, memory impairment, and
depressed mood [12, 13]. Long-term adherence with CPAP
therapy has also been shown to improve blood pressure and
cardiovascular morbidity and mortality [14]. Conversely,
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OSA symptoms return when CPAP therapy is discontinued
[15]. Unfortunately, CPAP therapy can take some time to get
used to, and long-term adherence with therapy can be chal-
lenging. Historically, CPAP adherence rates have been ≈50 %
and when applying Medicare’s definition of adherence (≥4 h
CPAP usage each night for 70 % of nights during a 30
consecutive-day period anytime during the first 90 days of
initial usage), the rate has been reported to be as low as
46 % [14, 16, 17]. However, more recent reports have docu-
mented adherence rates of 60–85 % when more intensive
follow-up and educational protocols are used [18].
Lack of adherence with long-term regimens is an ongoing
challenge for both patients and healthcare providers. It has been
estimated that non-adherence results in annual costs of $290 bil-
lion in the USA alone [19]. World Health Organization (WHO)
data indicate that patients with chronic diseases only adhere to
their doctor’s long-term recommended therapy 50 % of the time
[19]. Such data led to the conclusion that “interventions aimed at
improving adherence would provide a significant positive return
on investment through primary prevention (of risk factors) and
secondary prevention of adverse health outcomes” [19].
Telehealth (TH) has been defined as the delivery of health-
related services and information via telecommunications tech-
nologies. The development and increasing availability of TH
technology offers the opportunity to provide quality care
while effectively managing costs. Chronic diseases require
long-term commitment of resources for a successful therapy
program and, as such, are an excellent area to apply TH
technology.
U-Sleep (ResMed Corp) is a TH program that uses a multi-
media approach to contact patients about their CPAP use.
When usage falls, e-mail and text messages are sent to encour-
age patients to use CPAP more regularly. Electronic messages
are also sent to the patient’s clinician, with triggered alerts to
further assist in CPAP management. Clinicians also remotely
monitor their patients’ progress using U-Sleep technology via
metrics including daily usage, apnea-hypopnea index (AHI)
values, and leak. There are currently no published clinical
research studies on use of U-Sleep technology as a tool to
facilitate management of OSA patients.
This study compared the U-Sleep program with a standard-
of-care (SOC) program in patients with OSA receiving CPAP
therapy for the first time. The primary objective was to com-
pare adherence rates and healthcare professional (HCP) time
(resource use) in the two groups.
Methods
This randomized, prospective, non-blinded study was con-
ducted by Sleep Data Holdings, LLC, a Joint Commission
on Accreditation of Healthcare Organizations-accredited
CPAP durable medical equipment provider in Southern
California, USA. The study protocol, informed consent form,
and Health Insurance Portability and Accountability Act
(HIPAA) form were approved by the Chesapeake
Institutional Review Board. Informed consent was obtained
from all individual participants included in the study.
Subjects
Patients were recruited and evaluated at two Sleep Data loca-
tions (San Diego County) in March–August 2013.
Participants were consecutive patients referred to receive
CPAP for OSA. Inclusion criteria were age 18–80 years,
CPAP-naïve, confirmed OSA (AHI 5–70/h) diagnosis based
on polysomnography (PSG) or home sleep test. In addition,
patients were required to have access to and be able to utilize,
communication technology (text messaging, e-mail).
Exclusion criteria were prominent central apnea (>20 %),
claustrophobia, current use of mandibular repositioning de-
vice, or other OSA therapy. A simple randomization scheme
was used to allocate patients to CPAP treatment plus SOC or
TH.
CPAP therapy
At baseline, all patients had a 1-h education session with a
respiratory therapist (RRT) about OSA and its consequences,
proper use and maintenance of the CPAP device and mask,
and therapy expectations. All patients were provided with a
fixed or auto CPAP device, heated humidifier, modem, and
mask interface (S9 Elite, S9 AutoSet, H5i heated humidifier;
ResMed Corp.). Patients saw an RRT at all clinic visits; tele-
phone follow-up was performed by registered PSG techni-
cians (RPSGT).
Adherence monitoring
Patients randomized to SOC were dispensed a CPAP device
on Day 0, then contacted via phone on Days 1, 7, 14, 30, and
90 (Fig. 1). CPAP usage and efficacy data were tracked via the
wireless modem attached to the CPAP machine. Modem data
were accessed via ResMed’s EasyCare Online (ECO) plat-
form. Sleep Data SOC procedures include frequent phone
calls and return clinic visits as necessary.
Patients in the TH group were dispensed a CPAP device
on Day 0, along with a pamphlet about U-Sleep, which was
used to monitor adherence. U-Sleep is a secure, HIPAA-com-
pliant, web-based application that is designed to receive
CPAP device data and message patients and providers via text
and/or e-mail based on a customizable set of rules. At the time
of set up, patients were encouraged to log-in to the U-Sleep
website from home so that they could follow their therapy.
Sleep Data study staff were trained to set up and use the
software, which was provided to patients at no charge. Initial
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patient contacts were triggered by ≥1 of five intervention
points based on metrics (AHI, leak, therapy hours) (Table 1).
After initial contact, subsequent contacts were in response to
an automated message or based on clinical judgment. All TH
patients received a final phone call on day 90. All patients
were contacted at day 90 and asked to rate how well the
follow-up program hadmet their expectations (on a scale from
1 to 5).
In both groups, all phone contacts were performed by an
RPSGT from Sleep Data using a standardized script.
Additional telephone contacts or clinic visits were scheduled
as deemed clinically necessary by the RPSGT for evaluation
of issues such as highmask leak, appropriate pressure settings,
AHI elevation, and daily usage. Tasks undertaken at clinic
visits included mask refit, patient re-education and training
with an RRT, provision of a copy of CPAP therapy data down-
loads, and machine performance evaluations.
Resource use
The total number of contacts was recorded. Contacts were
categorized as contact attempt (e.g., staff left a phone message
with patient to follow up; 4 min), phone contact (RPSGT
communication with patient; 9 min), and clinic visits (e.g.,
mask refitting and education performed by an RRT; 30 min).
Times assigned to each contact were determined based on a
systematic review of Sleep Data’s clinical experience.
Study endpoints
The primary endpoints were CPAP adherence (use for ≥4 h/
night on 70 % of nights during a 30 consecutive-day period
anytime during the first 90 days of initial usage) and resource
use. The adherence rate was the percentage of patients who
achieved Medicare adherence. Whether patient adherence
with CPAP in the TH group was superior to the published
average of 50 % [13] was also determined.
Sample size
Equivalence in CPAP adherence was defined as a <20 % dif-
ference in rates between the SOC and TH groups. Assuming
an expected adherence rate of 70 % (based on historical Sleep
Data rates), with a power of ≥80 % (one-tailed alpha 0.05) to
detect a ≥20 % difference, the enrolment target was 69
patients/group [20]. For comparing adherence in the TH group
to the global average, a sample size of 37 patients/group
would have ≥80 % power (one-tailed alpha 0.05) to detect a
difference of ≥20 %, assuming an expected adherence rate for
the TH group of 70 % and a published average of 50 %.
Statistical analysis
Primary endpoint analyses were generated for the intention-to-
treat (ITT) and completed cases (CC) populations. The ITT
population included all randomized patients except two who
withdrew consent. Patients with no compliance data, and one
patient who never enrolled in the U-Sleep program, were con-
sidered non-adherent to CPAP; for those lost-to-follow-up,
adherence results for the last available assessment were used.
The CC population included patients who completed the study
according to the protocol. Additional analyses were conducted
in the CC population without imputation for missing values.
Equivalence in CPAP adherence between the two treatment
groups was tested using a two-sided 95 % confidence interval
(CI) for the difference in proportions. The null hypothesis is
rejected and equivalence established if the upper limit of the
CI is ≤20 %. The superiority hypothesis (TH adherence vs.
published average adherence) was tested using a two-sided
exact binomial test of the TH adherence proportion compared
to typical published average adherence; a two-sided 95 % CI
was calculated for the TH adherence proportion.
Baseline characteristics and 90-day evaluations were com-
pared between treatment groups using Student’s t test for con-
tinuous variables and chi-square or Fisher’s exact tests for
categorical variables, as appropriate. Wilcoxon rank sum tests
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Fig. 1 Study design. CPAP continuous positive airway pressure, OSA
obstructive sleep apnea
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were employed when a non-parametric test of continuous var-
iables was warranted. P values of <0.05 were considered sta-
tistically significant. Analyses were generated using SAS soft-
ware, version 9.2 or greater.
Results
All approached patients consented to participate (n = 140); 18
patients did not complete the 90-day study (16 lost to follow-
up, 2 withdrew consent) (Fig. 2). The ITTand CC populations
comprised 138 and 122 patients, respectively. Baseline char-
acteristics were similar in the TH and SOC groups (Table 2).
CPAP therapy had similar effectiveness in both treatment
groups, based on residual AHI and Epworth Sleepiness scale
score.
Primary endpoint (ITT)
Medicare adherence rates were 69.6 % in the TH group and
68.1 % in the SOC group (p = 0.85). The upper 95 % confi-
dence limit of the difference between groups was 14.0 %,
meeting predefined equivalence criteria. The Medicare adher-
ence rate in the TH group was 69.6 % (95 % CI 57.3–80.1 %)
compared with the published average of 50 % (p = 0.002).
Primary endpoint (CC)
Adherence rates were excellent and similar in both groups
(p = 0.22) (Table 3). The Medicare adherence rate in the TH
group was 82.8% (95%CI 70.6–91.4%), significantly higher
than the published average of 50 % (p < 0.0001). The
Medicare adherence rate in the SOC group was 73.4 %.
The upper 95 % confidence limit for the difference in
Medicare adherence rates was 5.2 %, again meeting equiva-
lence criteria. Themajority of patients in both groups achieved
Medicare adherence within the first 30 days of CPAP initia-
tion, and time to reach target adherence was similar in the two
groups (Table 3 and Fig. 3). Mean CPAP usage and the per-
centage of days that patients used CPAP for ≥4 h were slightly,
but not significantly, higher in the TH versus SOC group.
Multiple logistic regression analysis evaluating the effect
of baseline characteristics on adherence rates showed that age
and AHI at baseline were significantly associated with
Table 1 U-Sleep notification
triggers Trigger To whom Method
No CPAP data for 2 consecutive days Patient and provider E-mail and/or text
CPAP usage <4 h for 3 consecutive nights Patient and provider E-mail and/or text
Median mask leak >24 L/min for 2 consecutive days Provider E-mail
AHI >15/h for 5 consecutive days Provider E-mail
CPAP usage met Medicare criteria for adherence Patient and provider E-mail and/or text
Randomized
n=140













Fig. 2 Patient flow through the
study. TH telehealth, SOC
standard of care
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adherence. Adherent patients were significantly older than
non-adherent patients and had a higher baseline AHI
(Table 4).
Program acceptance
The majority of TH patients (92.8 % [52/56]) stated that the
new approach to monitoring met or exceeded their expecta-
tions compared with 94.5 % (52/55) in the SOC group
(p = 0.82).
Resource use
There was a significant reduction in the mean aggregate time
required to coach a patient in the TH versus SOC group
(Table 5). The number of follow-up clinic visits was similar
in the two groups; only 17/58 patients (19 visits) in the TH
group and 18/64 patients in the SOC group (20 visits) had a
clinic visit. The mean total number of contacts was
significantly lower in the TH group (2.2 ± 2.6/patient) com-
pared with the SOC group (7.8 ± 4.1/patient; p < 0.0001),
corresponding to a 59 % reduction in labor with the TH mon-
itoring program. In CPAP-adherent patients, labor time was
significantly lower in the TH versus SOC group (Table 5).
Discussion
In this study, TH monitoring of CPAP adherence using the U-
Sleep platform required 59% less coaching labor than an SOC
model, with equivalent adherence and efficacy. Adherence
was achieved quickly, particularly in the TH group, nearly
two thirds of whom had achieved Medicare-defined CPAP
adherence within 30 days.
Previous studies examining the use of TH strategies for
managing OSA patients have had varying results [13, 14,
17, 19, 21]. Few have explored resource utilization. The
TELEPAP study was a randomized, controlled clinical study
Table 2 Baseline patient
characteristics Characteristic TH group (N = 69) SOC group (N = 69) p value
Age, years (mean±SDa) 52.3 ± 10.6 50.0 ± 11.7 0.23
Male sex, n (%) 50/69 (72.5) 45/69 (65.2) 0.36
Body mass index, kg/m2 (mean ± SD) 33.5 ± 8.2 32.9 ± 7.1 0.63
Ethnicity, n (%) (68) (61)
Caucasian 49/68 (72.1) 50/61 (82.0) 0.34
Hispanic 11/68 (16.2) 4/61 (6.6)
African-American 3/68 (4.4) 2/61 (3.3)
Asian 5/68 (7.4) 4/61 (6.6)
Other 0 (0) 1/61 (1.6)
ESSb score (n = 66) (n = 68)
Mean ± SD 10.9 ± 4.7 10.2 ± 5.7 0.42
Median 11.0 10.0
AHIc/h (n = 69) (n = 69)
Mean ± SD 33.4 ± 24.5 27.4 ± 18.0 0.23
Median 27.2 23.2
PAP device, n (%)
S9 Elite 59/69 (85.5) 58/69 (84.1) 0.81
AutoSet 10/69 (14.5) 11/69 (15.9)
Mask type, n (%)
FFMd 20/68 (29.4) 20/69 (29.0) 0.90
Nasal mask 39/68 (57.4) 38/69 (55.1)
Nasal pillow 9/68 (13.2) 11/69 (15.9)
Device therapy setting, cmH2O (n = 58) (n = 58)
Mean ± SD (n) 10.6 ± 2.5 10.5 ± 2.0 0.81
Median 10.0 10.0
a Standard deviation
b Epworth Sleepiness Scale
c Apnea-hypopnea index
d Full face mask
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in 51 patients with newly diagnosed OSA [16]. The results did
not show an advantage in adherence or efficacy for
telemonitoring. With respect to labor requirements, it was as-
sumed that standard clinical care was the lower cost option.
To our knowledge, there is only one other study documenting
reduced labor requirements with TH [21]. A significant reduction
in nursing time per patient in CPAP users managed using a
wireless, remote monitoring system (ResTraxx Online
System®; ResMed) compared with control was documented.
DeMolles and colleagues used motivational interviewing tech-
niques administered via an automated telephone-linked commu-
nication system to promote CPAP use [22]. CPAP use signifi-
cantly increased in the telemedicine group, by 1 hour at 6months
and 2 hours at 12 months; labor costs were not assessed. In a 2-
month pilot study in 45 newly diagnosed OSA patients,
telemonitoring was as effective as usual care in achieving
CPAP adherence and efficacy, but economic efficiency and labor
requirements were not addressed [20]. Fox and colleagues ran-
domized 75 patients in a 3-month study comparing SOC with a
web-based telemonitoring application without automated mes-
saging [23]. The telemedicine group had increased CPAP usage,
and use of telemedicine was a significant predictor of CPAP
adherence. However, on average, telemedicine patients required
an extra hour of research coordinator time to achieve the im-
provement. The authors postulated that the additional labor cost
associated with the TH approach might be worth the investment
because of the improved adherence achieved.
In the current study, there was no significant difference in
adherence between the TH and SOC groups. This may be
because the overall CPAP adherence rate in the SOC group
was at the high end of those reported in the literature. The
study was designed to detect a 20 % difference in adherence
between the SOC and TH groups, with an expected SOC
group adherence rate of 70 %. To detect a significant
Table 3 Adherence results in the completed cases population
TH SOC p value
Medicare adherence rates N = 58 N = 64
Patients achieving adherence in first 30 days, n (%) 36 (62.1) 34 (53.1) 0.40
Patients achieving adherence within 31–60 days, n (%) 10 (17.2) 8 (12.5)
Patients achieving adherence within 61–90 days, n (%) 2 (3.5) 5 (7.8)
Patients not achieving adherence during the study, n (%) 10 (17.2) 17 (26.6)
Total patients achieving adherence at any time, n (%) 48 (82.8) 47 (73.4) 0.22
Average time to achieve adherence, days (n = 48) (n = 47)
Mean±SDa (range) 30.0 ± 12.2 (21–73) 34.0 ± 18.3 (21–83) 0.21
Usage N = 58 N = 64
Daily usage, h
Mean ± SD (range) 5.1 ± 1.9 (0.4–9.1) 4.7 ± 2.1 (0.1–9.0) 0.24
Median 5.5 4.9
Days CPAP used for >4 h, % patients






































Fig. 3 Average time spent on
follow-up care by time from
initiation of CPAP
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difference between the two groups, adherence in the TH group
would need to have been 90 %. Although the SOC techniques
were clearly successful at obtaining adherence, they required
significant time investment from HCPs, and this is expensive.
We speculate that the decrease in resource use in the TH group
can largely be attributed to a marked reduction in the require-
ment for HCPs tomanually review adherence data, identify at-
risk patients, and provide coaching. Instead, automated noti-
fications were delivered to the patient and their care provider.
The reduction in labor required in the TH group was especial-
ly evident in the savings associated with coaching patients
who reached adherence within the first 30 days (Fig. 3). The
TH program did not require any additional labor if the patient
was responding well to CPAP therapy. In contrast, the SOC
model required an intense labor investment, particularly dur-
ing the first month.
The TH technology allowed personnel resources to be
diverted to patients who were non-adherent with therapy or
were having one of a defined set of clinical complications
(e.g., increased AHI, high leak). The rule sets that trigger
patient and/or provider notifications can be customized based
on the specific requirements and scope of each healthcare
provider and patient population. Patient satisfaction data indi-
cated that the TH program met patient expectations just as
effectively as the SOC program.
There are some limitations to this study. Firstly, the ability
of the study to detect a significant difference in adherence and
daily usage between the TH and SOC groups was reduced by
the exclusion of 18 patients from the final analysis and the
high adherence rate in the SOC group. Of the 18 patients with
insufficient data, 12 were from the TH group and 6 were from
the SOC group. Examination of the characteristics of these
patients did not provide any explanation for the difference in
dropout rates between the two groups, and there is no evi-
dence that treatment allocation played any role. Secondly,
the findings of this study may not be widely generalizable
for the following reasons. Sleep Data’s SOC program utilizes
frequent phone calls to follow and coach patients, which can
be labor-intensive. Therefore, the coaching labor time saved
with the U-Sleep program might be greater compared with
less rigorous programs. In addition, the TH arm relied heavily
on access to a phone network or the internet, which, although
Table 4 Characteristics of
adherent and non-adherent
patients
Adherent Non-adherent p valuea
Age, years—mean ± SDb (range) [n]
TH 52.2 ± 11.3 (20–78) [n = 48] 48.3 ± 7.1 (35–57) [n = 10] 0.0055
SOC 52.9 ± 12.2 (30–77) [n = 47] 44.0 ± 6.1 (32–54) [n = 17]
Baseline AHIc, /h—mean ± SD (range) [n]
TH 37.8 ± 26.7 (5.3–110.0) [n = 48] 27.1 ± 17.4 (6.1–58.8) [n = 10] 0.0609
SOC 30.4 ± 15.9 (6.4–67.6) [n = 47] 23.5 ± 23.3 (6.9–99.8) [n = 17]
a Based on maximum likelihood estimates in the multiple regression model
b Standard deviation
c Apnea-hypopnea index
Table 5 Resource utilization
based on patient contacts TH (n = 58) SOC (n = 64) p value
Total time utilized
Contact attempt, minutes (4 min each) 116 920
Follow-up contact, minutes (9 min each) 702 2214
Clinic visit, minutes (30 min each) 570 600
Total time for follow-up care, min 1388 3734
Time for follow-up care per patient, min
Mean±SDa (range) 23.9 ± 26.3 (0–107) 58.3 ± 25.0 (18–133) <0.0001
Median 18.0 52.5
Time per patient—based on level of
adherence, min
Adherent patients, min (n = 48) (n = 47)
Mean ± SD 20.7 ± 24.6 53.7 ± 20.8 <0.0001
Non-adherent patients, min (n = 10) (n = 17)
Mean ± SD (n) 39.5 ± 29.6 71.2 ± 31.1 0.07
a Standard deviation
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commonplace, is by nomeans universal. In particular, some of
the most challenging patients are those in lower socioeconom-
ic groups who do not have access to these communication
tools. Thus, some patients may not have the ability to partic-
ipate in a TH program. Thirdly, the time ascribed to each
follow-up encounter was based on Sleep Data’s historical av-
erages and not measured directly. It is possible that although
the number of phone calls made to TH patients was markedly
reduced, their duration might have been longer. Lastly, al-
though there was close communication between Sleep Data
and the prescribing physicians, CPAP therapy for all patients
was primarily being managed by Sleep Data’s professionals;
this study did not gather detailed information about interven-
tions that might have been performed by the prescribing phy-
sician without Sleep Data’s knowledge.
This study also has a number of strengths. The protocol
was designed to overcome some of the limitations of previous
studies involving telemedicine and OSA. This study included
more than one study center, enrolled a larger number of pa-
tients and utilized objective adherence data on which to base
conclusions. In addition, the determination of resource utili-
zation associated with TH versus SOC has not been widely
analyzed previously. Finally, the TH system used, U-Sleep, is
a HIPAA-compliant program that is currently available and
provides a standardized model that can be applied in a variety
of clinical environments to optimize treatment of OSA
patients.
As healthcare payment structures in the USA continue to
evolve, there is an increasing pressure on healthcare providers
to focus on business efficiency, especially cost management.
According to the Centers forMedicare andMedicaid Services,
total US healthcare spending was $2.8 trillion in 2012, up
3.7% versus 2011 [17]. Given such a heavy economic burden,
more streamlined approaches to providing healthcare, such as
TH, are necessary to maintain quality healthcare while reduc-
ing costs.
In conclusion, the U-Sleep TH intervention was associated
with excellent adherence to CPAP therapy in newly diagnosed
OSA patients. The U-Sleep program also significantly re-
duced the amount of HCP time that was needed to achieve
adherence and efficacy comparable to the SOC model.
Whether these benefits translate into better cost effectiveness
remains to be determined.
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